http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
남윤성,Nam, Yun-Seong 대한인쇄문화협회 2006 프린팅코리아 Vol.51 No.-
청주MBC 남윤성 PD의 "직지"에 대한 관심은 뜨겁고도 집요할 정도이다. 그는 1995년 이래 "직지"관련 다큐를 6편 제작해 왔다. 그가 그동안 제작해온 다큐는 모두 굵직굵직한 상도 많이 받아왔지만, 수상실적보다 더욱 중요한 것은 "직지"라는 하나의 아이템을 가지고 끊임없이 다큐멘터리를 만들어 내고 있다는 것이다. 그의 열정과 집념에 박수를 보내며 남윤성 PD의 7번째 "직지"관련 다큐 제작기를 싣는다. 이번 특집프로그램은 청주MBC 홈페이지를 방문하면 '다시보기'로 볼 수 있다.
Bromocriptine 질투여로 치료된 프로락틴과다증 1례
남윤성,이우식,박찬,윤태기,차광열,Nam, Yoon-Sung,Lee, Woo-Sik,Park, Chan,Yoon, Tae-Ki,Cha, Kwang-Yul 대한생식의학회 1999 Clinical and Experimental Reproductive Medicine Vol.26 No.3
Objective: To report the efficacy of vaginally administered bromocriptine. Material and Method: Case report. Results: The prolactin level was significantly decreased after the administration of bromocriptine vaginally. Conclusions: The vaginal administration of bromocriptine can be an alternative to oral administration in patients with hyperprolactinemia who show severe side effects.
남윤성,한세열,최동희,윤태기,차광열,Nam, Y.S.,Han, S.Y.,Choi, D.H.,Yoon, T.K.,Cha, K.Y. 대한생식의학회 1999 Clinical and Experimental Reproductive Medicine Vol.26 No.1
A successful outcome of pregnancy requires an efficient uteroplacental vascular system. Since this system may be compromised by disorders of haemostasis associated with a prothrombotic state, maternal thrombophilia might be a risk factor for fetal loss. Hereditary deficiencies of the naturally occuring anticoagulants are well recognized conditions predisposing to recurrent venous thromboembolism. Since thrombotic phenomena have been implied as a cause of abortion and stillbirth, these deficiencies might increase the risk of fetal demise. We have experienced a case of antiphospholipid syndrome associated with protein C deficiency in patient with recurrent spontaneous abortion. So we report this case with a brief review of literatures.
Pergolide에 반응한 Bromocriptine 저항성 고프로락틴혈증 1례
남윤성,한세열,최동희,윤태기,차광열,Nam, Y.S.,Han, S.Y.,Choi, D.H.,Yoon, T.K.,Cha, K.Y. 대한생식의학회 1999 Clinical and Experimental Reproductive Medicine Vol.26 No.2
Dopamine agonists are commonly used in the medical treatment of prolactinomas. Bromocriptine has been the most widely used ergot derivative for two decades. Its oral administration, at a daily dose of $2.5{\sim}7.5mg$, restored normal gonadal function and normoprolactinemia in about 80% of patients. Nevertheless, a subset of patients could not achieve normal prolactin levels or resume normal gonadal function despite $15{\sim}30mg$/day bromocriptine for at least 6 months. Subsequently, these prolactinomas were consedered to be resistant to bromocriptine. The percentage of bromocriptine - resistant prolactinoma patients reported in the literature varies between 5 and 17% according to the series. Patients with bromocriptine resistance or bromocriptine intolerance have, however, been treated with other dopamine agonists, such as lysuride, pergolide, cabergoline, or quinagolide. Until cabergoline recently gained a product licence in the UK, there was no alternative dopamine agonist with a licence for this purpose. Quinagolide (CV $205{\sim}502$, Norprolac, Sandoz) is a nonergot dopamine agonist with improved selectivity for the D2 receptor, designed to retain the active pharmacophore of bromocriptine without the ergot moiety that might be responsible for side - effects. We have experienced a case of bromocriptine resistant hyperprolactinemia which was reponsive to pergolide. So we report this case with a brief review of literatures.